Trial intelligence / Profile preview

Prasugrel for bronchial hyperresponsiveness and airway inflammation in chronic asthma (PRINA)

2010-023945-31Phase 2Completed

Sponsor
ASST Santi Paolo e Carlo
Start
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of prasugrel in asthma (2 arms), sponsored by ASST Santi Paolo e Carlo. Primary endpoint: Bronchial hyperresponsiveness to mannitol. Started Mar 2012; status: completed.

02

Drugs

prasugrel
03

Conditions

asthma

Beyond the preview

Go deeper on 2010-023945-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-023945-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call